Zweig Di Menna Associates LLC Exact Sciences Corp Transaction History

Zweig Di Menna Associates LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$35.61 - $76.23 $3.7 Million - $7.92 Million	-103,940 Closed	0 $0
Q1 2022 Apr 25, 2022	BUY	$57.56 - $82.54 $5.98 Million - $8.58 Million	103,940 New	103,940 $7.27 Million
Q4 2021 Jan 27, 2022	SELL	$72.5 - $100.68 $4.07 Million - $5.65 Million	-56,113 Closed	0 $0
Q3 2021 Oct 25, 2021	BUY	$90.24 - $124.05 $90,240 - $124,050	1,000 Added 1.81%	56,113 $5.36 Million
Q2 2021 Jul 29, 2021	BUY	$93.66 - $139.27 $5.16 Million - $7.68 Million	55,113 New	55,113 $6.85 Million
Q4 2019 Jan 30, 2020	SELL	$77.66 - $99.74 $3.3 Million - $4.24 Million	-42,500 Closed	0 $0
Q3 2019 Oct 31, 2019	BUY	$90.37 - $122.49 $3.84 Million - $5.21 Million	42,500 New	42,500 $3.84 Million
Q1 2019 Apr 29, 2019	SELL	$61.98 - $96.5 $4.91 Million - $7.64 Million	-79,210 Closed	0 $0
Q3 2018 Oct 15, 2018	SELL	$48.29 - $80.6 $4.75 Million - $7.93 Million	-98,330 Reduced 55.38%	79,210 $6.25 Million
Q2 2018 Aug 01, 2018	SELL	$37.84 - $69.96 $17.6 Million - $32.5 Million	-464,118 Reduced 72.33%	177,540 $10.6 Million
Q1 2018 May 07, 2018	BUY	$39.82 - $57.53 $13.4 Million - $19.4 Million	336,883 Added 110.53%	641,658 $25.9 Million
Q4 2017 Feb 12, 2018	SELL	$46.49 - $60.51 $5.86 Million - $7.63 Million	-126,066 Reduced 29.26%	304,775 $16 Million
Q3 2017 Nov 06, 2017	SELL	$37.05 - $47.12 $130,267 - $165,673	-3,516 Reduced 0.81%	430,841 $20.3 Million
Q2 2017 Aug 07, 2017	BUY	N/A	434,357	434,357 $15.4 Million

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Zweig Di Menna Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Zweig Di Menna Associates LLC with notifications on news.